Cisco Sys (CSCO) Holder Bell State Bank & Trust Raised Its Holding; As Meridian Bioscience (VIVO) Stock Value Rose, Cardinal Capital Management Decreased Its Stake

January 18, 2018 - By Henry Gaston

Bell State Bank & Trust increased its stake in Cisco Sys Inc (CSCO) by 22.58% based on its latest 2017Q3 regulatory filing with the SEC. Bell State Bank & Trust bought 22,430 shares as the company’s stock declined 7.50% while stock markets rallied. The institutional investor held 121,781 shares of the technology company at the end of 2017Q3, valued at $4.10M, up from 99,351 at the end of the previous reported quarter. Bell State Bank & Trust who had been investing in Cisco Sys Inc for a number of months, seems to be bullish on the $204.17B market cap company. The stock increased 0.24% or $0.1 during the last trading session, reaching $41.3. About 17.04M shares traded. Cisco Systems, Inc. (NASDAQ:CSCO) has risen 13.20% since January 18, 2017 and is uptrending. It has underperformed by 3.50% the S&P500.

Amy Minella decreased its stake in Meridian Bioscience Inc (VIVO) by 46.96% based on its latest 2017Q3 regulatory filing with the SEC. Cardinal Capital Management sold 26,258 shares as the company’s stock rose 6.67% with the market. The hedge fund run by Amy Minella held 29,659 shares of the in vitro & in vivo diagnostic substances company at the end of 2017Q3, valued at $424,000, down from 55,917 at the end of the previous reported quarter. Cardinal Capital Management who had been investing in Meridian Bioscience Inc for a number of months, seems to be less bullish one the $632.50 million market cap company. The stock decreased 1.97% or $0.3 during the last trading session, reaching $14.95. About 337,632 shares traded or 13.33% up from the average. Meridian Bioscience, Inc. (NASDAQ:VIVO) has declined 26.84% since January 18, 2017 and is downtrending. It has underperformed by 43.54% the S&P500.

Investors sentiment decreased to 1.02 in 2017 Q3. Its down 0.16, from 1.18 in 2017Q2. It fall, as 74 investors sold CSCO shares while 637 reduced holdings. 107 funds opened positions while 619 raised stakes. 3.60 billion shares or 0.03% more from 3.60 billion shares in 2017Q2 were reported. The New York-based Richard Bernstein Advsrs Limited Liability has invested 0.63% in Cisco Systems, Inc. (NASDAQ:CSCO). Creative Planning holds 526,337 shares. First Dallas Inc has invested 0.6% in Cisco Systems, Inc. (NASDAQ:CSCO). Profund Limited Company owns 429,327 shares. Rockefeller Fincl Services has invested 0.28% in Cisco Systems, Inc. (NASDAQ:CSCO). Premier Asset Mngmt invested in 0.32% or 42,175 shares. Eulav Asset stated it has 0.14% in Cisco Systems, Inc. (NASDAQ:CSCO). 8,956 are held by Perritt Management Inc. Ims Management has 8,360 shares for 0.18% of their portfolio. Stanley stated it has 0.79% in Cisco Systems, Inc. (NASDAQ:CSCO). Edge Wealth Mgmt Lc has 358,200 shares. Asset Mngmt reported 12,708 shares. Warren Averett Asset Lc holds 0.17% or 23,997 shares in its portfolio. Fort Limited Partnership stated it has 748,150 shares or 6.19% of all its holdings. Crestpoint Cap Limited Com has 58,000 shares for 0.87% of their portfolio.

Among 37 analysts covering Cisco Systems Inc. (NASDAQ:CSCO), 24 have Buy rating, 0 Sell and 13 Hold. Therefore 65% are positive. Cisco Systems Inc. had 135 analyst reports since August 4, 2015 according to SRatingsIntel. Barclays Capital maintained Cisco Systems, Inc. (NASDAQ:CSCO) rating on Thursday, May 19. Barclays Capital has “Overweight” rating and $31 target. The firm has “Buy” rating given on Thursday, August 18 by Citigroup. Bank of America downgraded the stock to “Neutral” rating in Tuesday, April 5 report. The rating was maintained by Barclays Capital on Monday, August 15 with “Overweight”. As per Monday, February 8, the company rating was downgraded by Goldman Sachs. On Tuesday, June 13 the stock rating was maintained by Deutsche Bank with “Buy”. On Wednesday, September 14 the stock rating was maintained by Deutsche Bank with “Buy”. Jefferies maintained Cisco Systems, Inc. (NASDAQ:CSCO) on Friday, October 6 with “Buy” rating. As per Friday, July 21, the company rating was maintained by Wells Fargo. The rating was maintained by KeyBanc Capital Markets with “Overweight” on Thursday, August 18.

Since August 23, 2017, it had 0 insider buys, and 7 sales for $23.51 million activity. BARTZ CAROL had sold 200,000 shares worth $7.59 million on Thursday, December 14. CHANDLER MARK D also sold $2.11M worth of Cisco Systems, Inc. (NASDAQ:CSCO) shares. Another trade for 23,110 shares valued at $740,883 was made by Walker Karen on Monday, September 11. Another trade for 121,390 shares valued at $3.89M was made by Robbins Charles on Monday, September 11. Another trade for 250,000 shares valued at $7.79M was made by CHAMBERS JOHN T on Wednesday, August 23. Shares for $578,740 were sold by MCGEARY RODERICK C on Thursday, December 14.

Analysts await Meridian Bioscience, Inc. (NASDAQ:VIVO) to report earnings on January, 24. They expect $0.14 earnings per share, down 6.67% or $0.01 from last year’s $0.15 per share. VIVO’s profit will be $5.92 million for 26.70 P/E if the $0.14 EPS becomes a reality. After $0.15 actual earnings per share reported by Meridian Bioscience, Inc. for the previous quarter, Wall Street now forecasts -6.67% negative EPS growth.

Among 5 analysts covering Meridian Bioscience (NASDAQ:VIVO), 2 have Buy rating, 1 Sell and 2 Hold. Therefore 40% are positive. Meridian Bioscience had 10 analyst reports since July 28, 2015 according to SRatingsIntel. The rating was maintained by Piper Jaffray on Thursday, October 19 with “Sell”. The stock has “Sell” rating by Piper Jaffray on Thursday, September 21. The firm has “Sell” rating by Piper Jaffray given on Thursday, July 27. The rating was upgraded by Hilliard Lyons on Monday, March 28 to “Buy”. The rating was downgraded by Hilliard Lyons to “Neutral” on Monday, March 21. The firm has “Hold” rating given on Thursday, September 10 by Canaccord Genuity. Robert W. Baird maintained the stock with “Hold” rating in Thursday, October 19 report.

Investors sentiment increased to 1.37 in Q3 2017. Its up 0.02, from 1.35 in 2017Q2. It increased, as 12 investors sold VIVO shares while 42 reduced holdings. 24 funds opened positions while 50 raised stakes. 36.26 million shares or 2.14% more from 35.50 million shares in 2017Q2 were reported. Gotham Asset invested in 196,214 shares. Pinebridge Invs L P, New York-based fund reported 5,237 shares. Fuller And Thaler Asset Mngmt holds 1,050 shares. Hancock Holdg holds 0.05% or 76,397 shares. 53,075 were accumulated by North Star Mngmt. First Manhattan reported 0% of its portfolio in Meridian Bioscience, Inc. (NASDAQ:VIVO). Btim Corporation invested in 705,936 shares. D E Shaw has invested 0% in Meridian Bioscience, Inc. (NASDAQ:VIVO). First Advisors Ltd Partnership holds 0% or 33,480 shares. Commonwealth Equity Service holds 0% of its portfolio in Meridian Bioscience, Inc. (NASDAQ:VIVO) for 13,082 shares. Comerica National Bank holds 0% or 44,539 shares in its portfolio. Millennium Mgmt Limited Liability Com holds 0.02% or 731,335 shares in its portfolio. Ls Limited Liability Co stated it has 1,807 shares or 0% of all its holdings. Susquehanna Group Inc Limited Liability Partnership has invested 0% in Meridian Bioscience, Inc. (NASDAQ:VIVO). Hollencrest Secs Limited Liability Corp holds 0.07% in Meridian Bioscience, Inc. (NASDAQ:VIVO) or 35,400 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts